Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,2,0.82 [0.73-0.93],0.00129864728210145,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,2,0.76 [0.63-0.9],0.00195883946813647,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,2,2.28 [1.33-3.9],0.0027123348380076,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Inverse variance weighted,2,0.76 [0.62-0.93],0.00754502939266626,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,2,0.84 [0.73-0.96],0.0101811859391026,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,2,0.7 [0.53-0.93],0.0129946061309278,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,2,5.58 [1.18-26.49],0.030369817958504,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,2,1.19 [1.02-1.4],0.0319803861937987,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Inverse variance weighted,2,0.85 [0.73-0.99],0.0321705358385751,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Inverse variance weighted,2,0.7 [0.49-1],0.0505033502102852,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,2,0.8 [0.64-1],0.0522896576234935,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHILEUS,Inverse variance weighted,2,1.39 [1-1.93],0.0530896393009451,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,2,0.64 [0.41-1.01],0.0571503124859628,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,2,1.82 [0.98-3.37],0.0583123211216748,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,2,6.15 [0.93-40.78],0.0598404501550212,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,2,0.69 [0.47-1.02],0.0639347759971199,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,2,1.61 [0.97-2.7],0.068109653404056,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_ILEUS,Inverse variance weighted,2,1.36 [0.97-1.92],0.0784789593431161,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,2,1.61 [0.95-2.73],0.0791927511853828,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,2,0.73 [0.51-1.04],0.0821740982821915,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHRITISNAS,Inverse variance weighted,2,1.16 [0.98-1.38],0.0846639295596978,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,2,0.84 [0.69-1.03],0.100205954343987,cis
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,LUNG_CANCER_MESOT,Inverse variance weighted,2,0.73 [0.51-1.06],0.101824695868075,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,2,0.88 [0.76-1.03],0.104234322866159,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Inverse variance weighted,2,1.2 [0.96-1.51],0.109062277153909,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,2,1.54 [0.9-2.62],0.112173255662057,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,2,1.14 [0.97-1.33],0.113211825108166,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,2,0.93 [0.84-1.02],0.11503330736318,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_OTH,Inverse variance weighted,2,1.22 [0.95-1.57],0.118740257200153,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,2,0.5 [0.2-1.21],0.122203089378187,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,2,0.69 [0.43-1.1],0.122804817043682,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,2,1.51 [0.89-2.57],0.124586426060218,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,2,0.93 [0.84-1.02],0.12619057510685,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,Inverse variance weighted,2,0.73 [0.48-1.11],0.142389495476098,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,1.11 [0.96-1.29],0.143019459765316,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_WIDE,Inverse variance weighted,2,1.2 [0.94-1.55],0.14601195854788,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.22 [0.93-1.59],0.151533434463791,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Inverse variance weighted,2,0.87 [0.72-1.06],0.157623703833958,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,2,0.9 [0.79-1.04],0.157959899734991,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Inverse variance weighted,2,0.88 [0.74-1.05],0.16545651827291,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,2,0.87 [0.71-1.06],0.167934055436594,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,2,0.85 [0.68-1.07],0.16818469132953,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,2,0.78 [0.54-1.11],0.169312162213995,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,0.92 [0.82-1.04],0.170100009429703,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,2,1.09 [0.96-1.24],0.177795378412607,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,2,1.09 [0.96-1.24],0.180081288208913,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,2,1.16 [0.93-1.45],0.182044590912795,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,2,1.19 [0.92-1.53],0.182485128796025,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,2,1.62 [0.79-3.33],0.18565179278908,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_HERNIA,Inverse variance weighted,2,1.08 [0.96-1.21],0.194386215849458,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,2,0.55 [0.22-1.4],0.210124479711417,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,2,1.17 [0.91-1.49],0.212381002378189,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,2,1.26 [0.87-1.81],0.222703901532005,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,2,0.88 [0.71-1.08],0.224505415788977,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,2,0.78 [0.53-1.16],0.225778574370745,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,2,0.93 [0.83-1.04],0.228297825119933,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,2,0.63 [0.29-1.34],0.230022440029697,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,2,0.7 [0.39-1.25],0.230276943224794,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,2,0.62 [0.28-1.36],0.233518529482695,cis
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERBLOOD,Inverse variance weighted,2,1.39 [0.81-2.39],0.236634522690524,cis
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,G6_NEURO,Inverse variance weighted,2,1.07 [0.96-1.19],0.243657599566468,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,2,1.09 [0.94-1.27],0.247393239882293,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Inverse variance weighted,2,1.12 [0.92-1.37],0.247590072125877,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_ULCER,Inverse variance weighted,2,0.79 [0.54-1.18],0.251651107199475,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYMYALGIA,Inverse variance weighted,2,1.26 [0.84-1.87],0.266652872033016,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,2,1.24 [0.85-1.8],0.270513879254735,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,2,1.07 [0.95-1.21],0.270910651406431,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,2,0.91 [0.76-1.08],0.275625087782721,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,ULCERNAS,Inverse variance weighted,2,1.26 [0.83-1.89],0.27651863446202,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,2,0.93 [0.81-1.06],0.277793435509087,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,RESPIRATORYINSUFF,Inverse variance weighted,2,0.49 [0.13-1.85],0.292264772452672,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHCONN,Inverse variance weighted,2,0.82 [0.57-1.19],0.300580186971101,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,2,0.8 [0.51-1.23],0.305016535139846,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ALKALOSIS,Inverse variance weighted,2,0.6 [0.23-1.6],0.307831672347061,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,2,1.22 [0.83-1.78],0.314259951892396,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,2,1.21 [0.83-1.78],0.323086291764942,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,2,1.14 [0.88-1.48],0.323736223429627,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,2,1.12 [0.89-1.41],0.32411290216784,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,2,1.28 [0.78-2.13],0.330384087948971,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,0.85 [0.61-1.18],0.33710478860622,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,0.84 [0.59-1.2],0.338352538936567,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,2,0.77 [0.46-1.31],0.339113324774445,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,2,1.43 [0.68-3.02],0.343550655854336,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Inverse variance weighted,2,0.8 [0.5-1.27],0.344193559956432,cis
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,2,0.89 [0.7-1.13],0.344549361798125,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,2,1.08 [0.92-1.26],0.348711937391331,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,2,1.09 [0.91-1.3],0.351294035943013,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,2,0.93 [0.81-1.08],0.355051477504684,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,2,0.94 [0.82-1.07],0.356953339308748,cis
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,2,0.96 [0.88-1.05],0.359925191654301,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,2,1.06 [0.93-1.21],0.36083607192598,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,2,0.61 [0.2-1.8],0.367041230506793,cis
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,2,0.64 [0.24-1.7],0.367886978811387,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,2,0.96 [0.88-1.05],0.370381948091481,cis
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,2,1.2 [0.8-1.8],0.370733077289734,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,2,1.19 [0.81-1.75],0.37319703268662,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,2,1.07 [0.92-1.25],0.375955836650215,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,2,0.89 [0.7-1.15],0.380994389448812,cis
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,1.15 [0.84-1.58],0.390668141053395,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,2,0.86 [0.6-1.22],0.393767282380207,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,2,0.77 [0.42-1.41],0.39838755212443,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,2,0.92 [0.75-1.12],0.399598538141538,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,2,0.82 [0.5-1.34],0.424232650820748,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN_NAS,Inverse variance weighted,2,1.28 [0.69-2.37],0.433765850568216,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Inverse variance weighted,2,1.21 [0.74-1.98],0.437752124083976,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,2,1.06 [0.92-1.22],0.438767218479928,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,2,1.06 [0.92-1.22],0.456815066297045,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Inverse variance weighted,2,0.81 [0.47-1.41],0.464935640514477,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,2,0.91 [0.71-1.17],0.467030690830651,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,2,0.88 [0.63-1.24],0.472092573953471,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOMYELITIS,Inverse variance weighted,2,1.23 [0.7-2.15],0.480377202259621,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,2,0.92 [0.73-1.17],0.493027571554665,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,2,1.03 [0.94-1.13],0.501251409159558,cis
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,NEURODEGOTH,Inverse variance weighted,2,1.08 [0.86-1.35],0.502226167804811,cis
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Inverse variance weighted,2,0.96 [0.84-1.09],0.504184363037773,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,2,0.51 [0.07-3.84],0.511988947911866,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,2,0.69 [0.23-2.08],0.513727942300476,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,2,1.06 [0.89-1.25],0.518960028949468,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,2,1.15 [0.75-1.76],0.521856313269851,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERCONTACT,Inverse variance weighted,2,1.17 [0.73-1.87],0.526760987843448,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,2,1.3 [0.57-2.99],0.533450261181123,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DEMNAS,Inverse variance weighted,2,1.13 [0.76-1.68],0.534389830904797,cis
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,2,0.89 [0.61-1.3],0.536007080561118,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,2,0.89 [0.61-1.29],0.537895229997622,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,2,1.09 [0.83-1.44],0.542430478929929,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,2,0.82 [0.43-1.56],0.544200104057846,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Inverse variance weighted,2,1.07 [0.86-1.32],0.553401006270115,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,2,0.68 [0.19-2.48],0.561391961211113,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,2,1.09 [0.81-1.48],0.56176826664141,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Inverse variance weighted,2,0.96 [0.85-1.1],0.571667705972414,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,2,0.98 [0.89-1.06],0.575340035382227,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,2,0.89 [0.58-1.36],0.580822398478344,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,2,0.96 [0.84-1.1],0.581960685007724,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,2,1.18 [0.65-2.16],0.587531988449562,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,2,0.82 [0.4-1.68],0.590710780051502,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,2,1.07 [0.82-1.4],0.602605708912887,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,2,1.05 [0.86-1.29],0.604258740749322,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,2,1.03 [0.92-1.16],0.606766887778649,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,2,1.09 [0.78-1.52],0.615657496209725,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,2,0.89 [0.53-1.47],0.638543897801726,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,2,0.93 [0.66-1.29],0.647520790989227,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,2,0.92 [0.64-1.32],0.650954904937524,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_STR_EXH,Inverse variance weighted,2,0.94 [0.72-1.24],0.663886406128624,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,2,1.03 [0.9-1.18],0.675229683115138,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,2,0.89 [0.51-1.55],0.678084129369931,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Inverse variance weighted,2,0.98 [0.87-1.1],0.681882489730118,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,2,1.05 [0.82-1.34],0.687071200347257,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,2,1.09 [0.71-1.67],0.687544537594562,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,2,1.54 [0.18-13.15],0.690717710325479,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_STR_SAH,Inverse variance weighted,2,1.05 [0.82-1.34],0.698616706268093,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,2,1.07 [0.76-1.49],0.698948283670359,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,2,0.93 [0.66-1.33],0.707543912581151,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,2,1.09 [0.7-1.69],0.711862847219793,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,2,1.21 [0.41-3.56],0.732427037516247,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,2,0.95 [0.7-1.28],0.735915046503141,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,2,1.06 [0.77-1.45],0.741050596632777,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,2,1.03 [0.86-1.24],0.746697883417538,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,2,1.03 [0.88-1.2],0.748850528621181,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,2,1.1 [0.6-2.04],0.75350622113941,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,2,0.93 [0.59-1.46],0.754002638406147,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,2,1.08 [0.65-1.79],0.755879687628086,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,2,0.94 [0.63-1.4],0.760638397571977,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Inverse variance weighted,2,0.99 [0.91-1.07],0.761336496046193,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,2,0.95 [0.67-1.34],0.762061678125878,cis
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,G6_OTHNEU,Inverse variance weighted,2,1.02 [0.88-1.19],0.763655346534694,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,2,0.96 [0.72-1.28],0.767656330130233,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,2,0.89 [0.4-1.98],0.775275777941285,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,PNEUMOBACTKNOWN,Inverse variance weighted,2,0.92 [0.51-1.65],0.778624727588588,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Inverse variance weighted,2,1.01 [0.92-1.12],0.78175320562732,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,2,1.02 [0.9-1.15],0.790325880846351,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,2,1.02 [0.86-1.21],0.796112664253931,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,2,1.02 [0.87-1.19],0.809988012796225,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,2,0.96 [0.67-1.37],0.813594077733601,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,2,1.19 [0.27-5.18],0.816147556641575,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,2,0.96 [0.7-1.33],0.819996755240892,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,2,1.03 [0.78-1.37],0.82514040097873,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,2,0.98 [0.83-1.17],0.839849403055439,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,2,1.01 [0.9-1.14],0.84429864143692,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SLE,Inverse variance weighted,2,0.84 [0.15-4.78],0.847289714596003,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,2,0.94 [0.47-1.88],0.858849582411686,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,2,1.01 [0.88-1.16],0.871430708000728,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,2,0.99 [0.83-1.17],0.8721345344921,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_GIBLEEDING,Inverse variance weighted,2,1.02 [0.84-1.24],0.872264319138018,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,2,1.03 [0.73-1.44],0.874307337610711,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,2,0.96 [0.57-1.61],0.874908702071174,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,2,0.99 [0.85-1.15],0.879642011221167,cis
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,2,1.04 [0.65-1.65],0.882480107505081,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,2,0.97 [0.63-1.48],0.884571996037948,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_SKIN_SUBCUTAN,Inverse variance weighted,2,0.97 [0.68-1.39],0.885628633531862,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.02 [0.74-1.41],0.885692984272531,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,2,1.02 [0.78-1.33],0.887250516510103,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,2,1.05 [0.54-2.03],0.891885628121424,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1.04 [0.59-1.82],0.892168031705035,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,2,0.99 [0.89-1.11],0.892951436188092,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,2,1.05 [0.49-2.26],0.900001885142794,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,2,0.96 [0.52-1.79],0.90116455135635,cis
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,2,0.99 [0.8-1.22],0.901389829586197,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,2,1.12 [0.17-7.63],0.905288705080258,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,2,1.01 [0.82-1.24],0.912384964089426,cis
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Inverse variance weighted,2,0.99 [0.8-1.22],0.913455431074201,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,2,0.99 [0.82-1.19],0.91516852732083,cis
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,2,1.02 [0.68-1.53],0.923998840016259,cis
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,2,1.01 [0.85-1.19],0.938328509893443,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,2,0.98 [0.62-1.57],0.940518533040721,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,2,1.01 [0.82-1.23],0.955834129392716,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,2,1.02 [0.36-2.91],0.964594742274724,cis
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,2,0.99 [0.57-1.73],0.972295293829727,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,2,1.01 [0.59-1.73],0.973454326551515,cis
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,Inverse variance weighted,2,1 [0.82-1.23],0.979280661303157,cis
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,2,1 [0.77-1.31],0.979888247414283,cis
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,2,1 [0.88-1.13],0.98042001536172,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,2,1 [0.8-1.25],0.988926598252927,cis
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,2,1 [0.79-1.26],0.993117918636744,cis
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,2,1 [0.47-2.13],0.995427374974923,cis
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,9,1.1 [1.03-1.18],0.00556918450415165,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,9,1.34 [1.08-1.66],0.00843532226278762,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,9,1.33 [1.07-1.64],0.00897817563432675,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,9,1.35 [1.07-1.69],0.0104304541353821,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,9,1.22 [1.05-1.42],0.0107225561916155,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,9,1.28 [1.05-1.56],0.0143291206658297,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,9,1.7 [1.11-2.6],0.0149645880058999,trans
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,9,1.19 [1.03-1.36],0.0151847876476979,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,9,1.33 [1.04-1.69],0.0208181842351582,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,9,1.19 [1.02-1.38],0.0234566959053536,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,9,1.09 [1.01-1.17],0.0293976806823034,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,9,1.12 [1.01-1.24],0.0300102313463335,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,9,1.58 [1.04-2.41],0.0319272124436702,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,9,1.13 [1.01-1.27],0.0396725256632913,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,9,1.18 [1-1.38],0.0433326148863185,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,9,1.1 [1-1.2],0.0460795534541882,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,9,1.11 [1-1.23],0.0513761430123442,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,9,1.35 [0.99-1.85],0.0619992025410251,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,9,1.41 [0.98-2.01],0.0629222989013622,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHILEUS,Inverse variance weighted,9,1.25 [0.99-1.59],0.0634404212378719,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,9,1.11 [0.99-1.24],0.0658753741527561,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,9,1.35 [0.97-1.87],0.0713042197621491,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,9,1.07 [0.99-1.16],0.0730949552726085,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,9,1.12 [0.99-1.26],0.0751349261108913,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,9,1.17 [0.98-1.4],0.0795107009228603,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,9,0.7 [0.46-1.05],0.0821449544756749,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,9,1.15 [0.98-1.36],0.0845200485554029,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,9,1.2 [0.97-1.49],0.0923469735191251,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,9,1.06 [0.99-1.13],0.0926299637729057,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,9,1.32 [0.95-1.83],0.0947712839080529,trans
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,9,0.94 [0.88-1.01],0.100335525291365,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,9,1.11 [0.98-1.26],0.106203844969814,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,9,1.25 [0.95-1.64],0.10879566152175,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,9,1.25 [0.95-1.64],0.11628903021097,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,9,1.12 [0.97-1.3],0.117904260345713,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,9,1.12 [0.96-1.31],0.137666151654787,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_ILEUS,Inverse variance weighted,9,1.16 [0.95-1.41],0.149569111725582,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,9,1.12 [0.96-1.3],0.152885385944537,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,9,1.14 [0.95-1.36],0.155654554870884,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,9,1.12 [0.96-1.31],0.155991433407526,trans
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,Inverse variance weighted,9,1.1 [0.96-1.25],0.160475109588542,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,9,0.71 [0.43-1.17],0.177736292245776,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,9,1.09 [0.96-1.23],0.182677152568864,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_HERNIA,Inverse variance weighted,9,1.11 [0.95-1.28],0.18571290915193,trans
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,9,0.81 [0.6-1.11],0.19155152500305,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,9,1.14 [0.93-1.4],0.19341231700619,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,9,1.09 [0.96-1.25],0.198012395151738,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,9,1.15 [0.92-1.44],0.206876430963932,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,9,1.09 [0.95-1.25],0.212249488582986,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,9,1.13 [0.93-1.38],0.215898658233343,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,9,0.73 [0.43-1.22],0.22684458109605,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,9,1.55 [0.76-3.18],0.228462311656056,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,9,2.04 [0.63-6.64],0.237609821870839,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,9,0.79 [0.52-1.2],0.261308301881236,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,9,1.33 [0.81-2.19],0.265479702810488,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_OBSTRUREFLUROPATH,Inverse variance weighted,9,1.22 [0.86-1.73],0.275435024710248,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,9,1.07 [0.94-1.22],0.284418774639857,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,9,1.08 [0.93-1.26],0.292133934651874,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,9,1.21 [0.85-1.72],0.298352852809123,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,9,1.26 [0.8-1.99],0.311247298105609,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,9,1.22 [0.82-1.81],0.319464847769895,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,9,1.22 [0.83-1.8],0.320211033428234,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,9,1.09 [0.92-1.28],0.321224664186096,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,9,1.05 [0.95-1.16],0.324163134117038,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,9,0.94 [0.84-1.06],0.325304277438956,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,9,0.9 [0.73-1.11],0.333408336347346,trans
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,G6_OTHNEU,Inverse variance weighted,9,1.06 [0.94-1.19],0.336559383253595,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,9,0.6 [0.21-1.71],0.340299124710626,trans
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,9,1.2 [0.82-1.77],0.352854141329314,trans
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,9,0.93 [0.79-1.09],0.364000658299254,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,9,1.19 [0.81-1.73],0.373627473394508,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,9,0.56 [0.16-2.02],0.374454151110195,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,9,1.1 [0.89-1.38],0.378049579484888,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,9,2.44 [0.32-18.44],0.385902270800346,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,9,1.21 [0.78-1.89],0.39236840089338,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOMYELITIS,Inverse variance weighted,9,0.83 [0.54-1.28],0.394319260627349,trans
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERCONTACT,Inverse variance weighted,9,0.84 [0.55-1.26],0.398469263953233,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,9,1.05 [0.93-1.18],0.415193623968432,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,9,1.22 [0.75-1.97],0.41828878387613,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DEMNAS,Inverse variance weighted,9,1.2 [0.77-1.88],0.421238861129938,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,9,1.83 [0.42-7.94],0.421367784837309,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,9,1.09 [0.88-1.36],0.425378178311828,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,9,0.93 [0.76-1.12],0.432879744479549,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,9,1.06 [0.92-1.22],0.43924715876239,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,9,1.12 [0.83-1.51],0.445280413317517,trans
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,9,0.65 [0.21-2.05],0.460358078414198,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,9,1.07 [0.89-1.3],0.466029998530417,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,9,1.08 [0.87-1.35],0.473795795299884,trans
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,9,0.89 [0.63-1.24],0.476114476377623,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,9,1.1 [0.85-1.42],0.477972284205751,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,9,1.09 [0.86-1.38],0.478758737543323,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,9,0.87 [0.58-1.29],0.482413094155496,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,9,0.9 [0.66-1.22],0.496096984309687,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,9,1.09 [0.85-1.4],0.503859979156228,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,9,1.18 [0.72-1.92],0.510298686838011,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,9,1.2 [0.7-2.07],0.511316724486832,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,9,1.03 [0.94-1.14],0.512614557608275,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYMYALGIA,Inverse variance weighted,9,0.87 [0.58-1.32],0.51676797475114,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,ULCERNAS,Inverse variance weighted,9,0.86 [0.54-1.36],0.517387855832037,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,9,1.05 [0.91-1.2],0.519538857690722,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,9,1.17 [0.72-1.9],0.519991420847832,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,9,1.08 [0.85-1.36],0.524931723871704,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,9,0.92 [0.7-1.21],0.530350170568631,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,9,1.07 [0.87-1.3],0.531265986589929,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,9,1.34 [0.5-3.56],0.556806338434442,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,9,1.07 [0.85-1.35],0.558461212567536,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,9,0.88 [0.55-1.38],0.567805782924755,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,9,0.84 [0.44-1.58],0.584247210354168,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,9,0.96 [0.83-1.11],0.587862743819471,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,9,1.08 [0.81-1.43],0.600856801697168,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,9,1.03 [0.91-1.16],0.61695832795388,trans
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,9,0.95 [0.78-1.16],0.626855198339056,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,9,1.1 [0.75-1.6],0.628997938086561,trans
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERBLOOD,Inverse variance weighted,9,0.88 [0.52-1.5],0.647748254004435,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,9,0.9 [0.56-1.43],0.650542969058914,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,9,1.03 [0.91-1.16],0.655465914947535,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_OTHETNASKIDUR,Inverse variance weighted,9,0.86 [0.45-1.66],0.655991165753395,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,9,1.05 [0.86-1.27],0.657221716210945,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,9,1.07 [0.8-1.43],0.659847513004852,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,9,0.93 [0.65-1.32],0.665550401698991,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,9,1.14 [0.63-2.04],0.671656267336334,trans
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,9,0.94 [0.7-1.26],0.673140999842898,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,9,0.94 [0.7-1.26],0.674361249986511,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,9,1.03 [0.91-1.16],0.674678799363203,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,9,1.13 [0.64-2],0.677193487557869,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,9,1.07 [0.76-1.52],0.687940441610635,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,9,0.95 [0.73-1.23],0.690353709534752,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,9,1.04 [0.86-1.26],0.692239402838275,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,9,1.06 [0.77-1.47],0.707175258954991,trans
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,9,1.09 [0.68-1.74],0.734224906752897,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,9,1.03 [0.86-1.24],0.744664021302975,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,9,1.05 [0.76-1.47],0.757570009947129,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,9,0.94 [0.62-1.42],0.764914109801919,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,9,1.04 [0.79-1.39],0.766694974052689,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,9,0.89 [0.41-1.92],0.769225959042851,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,9,1.02 [0.92-1.12],0.772337702747125,trans
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,9,1.02 [0.87-1.21],0.785160150793423,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,9,0.93 [0.55-1.56],0.785397615907122,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,9,1.01 [0.92-1.12],0.790249240467839,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,9,1.02 [0.87-1.19],0.795577341197208,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_WIDE,Inverse variance weighted,9,1.03 [0.82-1.28],0.815903393680196,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,9,1.03 [0.78-1.36],0.817844076290868,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,9,0.98 [0.84-1.14],0.829347893706325,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,9,1.04 [0.74-1.46],0.836527956309252,trans
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,9,0.97 [0.7-1.34],0.841613995764797,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_OTH,Inverse variance weighted,9,1.02 [0.81-1.28],0.859696126151371,trans
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,NEURODEGOTH,Inverse variance weighted,9,0.97 [0.65-1.44],0.86403263209894,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,9,1.01 [0.89-1.14],0.865069572146313,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,9,0.99 [0.87-1.13],0.876720785555231,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,9,1.02 [0.72-1.46],0.903971217160405,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,9,1.02 [0.67-1.55],0.913700442958581,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,9,0.99 [0.89-1.11],0.91597502749845,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,9,0.98 [0.71-1.37],0.92598485142258,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,9,0.98 [0.67-1.45],0.936358812249203,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,9,1 [0.93-1.08],0.938046103791875,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,9,0.99 [0.77-1.27],0.939102285262868,trans
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,9,0.99 [0.77-1.28],0.955160303651202,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,9,1 [0.91-1.11],0.955169622500102,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,9,1.01 [0.81-1.25],0.956009258820951,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,9,1 [0.92-1.09],0.956424424092025,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,9,1.01 [0.57-1.8],0.969788656557474,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,9,1 [0.87-1.15],0.971423594737451,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,9,1 [0.86-1.16],0.974602369005836,trans
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,9,1 [0.89-1.11],0.975362799400963,trans
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,9,1 [0.86-1.17],0.97918726788167,trans
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,9,1 [0.92-1.09],0.981752553038677,trans
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,9,1 [0.76-1.33],0.98749099973625,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,9,1 [0.71-1.43],0.987558957159993,trans
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,9,1 [0.57-1.78],0.988064445853947,trans
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,9,1 [0.68-1.48],0.988871499765848,trans
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,9,1 [0.14-7.03],0.996936924546976,trans
